Wedica 50 Tablet

Indicated for, type 2 diabetes, when the first line treatment of metformin is not achieving the expected glycemic goals.

Oral Adult Tablet One 100mg tablet once weekly

Renal Failure Moderate Creatinine Clearance 30-<50: 50 mg once weekly.

Should be taken once weekly and same day every week.

Hypersensitivity

Patients with moderate kidney function disease. Hypoadrenalism or Hypopituitarism Malnutrition, irregular eating patterns, starvation Vigorous exercise This drug may cause hypoglycemia when used with other diabetes medication

Not Classi

Hypoglycemia, nasopharyngitis, elevated lipase. Acute pancreatitis, intestinal obstruction, atrial fibrillation, elevated liver enzyme

It works by inhibiting the activity of dipeptidyl peptidase 4 Trelagliptin inactivates glucagon-like peptide 1 (GLP-1) from secretion from the intestines to the blood via stimulation from oral intake of food, increases GLP-1 blood concentration and promotes blood glucose concentration-dependent insulin secretion from the pancreas.

Wedica 50 50mg Tablet manufactured by Beacon Pharmaceuticals Ltd.. Its generic name is Trelagliptin.